Clincosm LogoSign in Get a demo

chronic obstructive pulmonary disease, copd

Showing 1 - 7 of 7
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

COPD, COPD Trial in Wellington (Placebo, TD-4208 700 µg, TD-4208 350 µg)

Completed
Has Results
  • Chronic Obstructive Pulmonary Disease, COPD
  • Placebo
  • +3 more
  • Wellington, New Zealand
    P3 Research
Feb 22, 2022

COPD, COPD, Low Peak Inspiratory Flow Rate (PIFR) Trial in Rock Hill (Revefenacin, Spiriva Handihaler®, Placebo for Revefenacin)

Completed
Has Results
  • Chronic Obstructive Pulmonary Disease, COPD
  • Low Peak Inspiratory Flow Rate (PIFR)
  • Rock Hill, South Carolina
    Clinical Research of Rock Hill
Feb 22, 2022

COPD, COPD Trial in Poland, United States (QBW251, Placebo)

Completed
Has Results
  • Chronic Obstructive Pulmonary Disease, COPD
  • Birmingham, Alabama
  • +15 more
Dec 9, 2020

COPD, COPD Trial in Silkeborg (Tele Monitoring, using Tunstall monitoring device)

Completed
  • Chronic Obstructive Pulmonary Disease, COPD
  • Tele Monitoring, using Tunstall monitoring device
  • Silkeborg, Mid Region, Denmark
    Region Hospital of Silkeborg
Sep 30, 2019

COPD, COPD Trial in Hannover (QVA149, Placebo)

Completed
Has Results
  • Chronic Obstructive Pulmonary Disease, COPD
  • Hannover, Germany
    Novartis Investigative Site
Dec 10, 2018

COPD, COPD Trial in Worldwide (Roflumilast)

Completed
  • Chronic Obstructive Pulmonary Disease, COPD
  • Cities in California, California
  • +15 more
Oct 24, 2016

COPD, COPD Trial in Worldwide (Symbicort (budesonide/formoterol turbuhaler 320/9ug), Spiriva (tiotropium bromide 18ug))

Completed
Has Results
  • Chronic Obstructive Pulmonary Disease, COPD
  • Symbicort (budesonide/formoterol turbuhaler 320/9ug)
  • Spiriva (tiotropium bromide 18ug)
  • Concord, New South Wales, Australia
  • +92 more
Oct 10, 2012